Abstract:Marta Szukalska, 1 Bartosz F Grze&sacutekowiak, 2 Magdalena J Bigaj-Józefowska, 2 Marta Witkowska, 3, 4 Emilia Cicha, 5 Patrycja Sujka-Kordowska, 6 Izabela Miechowicz, 7 Micha&lstrok Nowicki, 6 Rados&lstrokaw Mrówczy&nacuteski, 3, 4 Ewa Florek 1 1 Laboratory of Environmental Research, Department of Toxicology, Poznan University of Medical Sciences, Pozna&nacute, Poland; 2 NanoBioMedical Centre, Adam Mickiewicz University, Pozna&nacute, Poland; 3 Faculty of Chemistry, Adam Mickiewicz University, Pozna&nacute, Poland; 4 Centre for Advanced Technologies, Adam Mickiewicz University, Pozna&nacute, Poland; 5 Laboratory of Experimental Animals, Poznan University of Medical Sciences, Pozna&nacute, Poland; 6 Department of Histology and Embryology, Poznan University of Medical Sciences, Pozna&nacute, Poland; 7 Department of Computer Science and Statistics, Poznan University of Medical Sciences, Pozna&nacute, Poland Correspondence: Marta Szukalska, Laboratory of Environmental Research, Department of Toxicology, Poznan University of Medical Sciences, Rokietnicka 3 Street, Poznan, 60-806, Poland, Email Purpose: Polydopamine nanoparticles (PDA NPs) have great potential in medicine. Their applications being widely investigated in cancer therapy, imaging, chemotherapy, photodynamic therapy (PDT), photothermal therapy (PTT), and tissue repair. The aim of our study was to assess the in vivo toxicity and changes in oxidative stress biomarkers in organs of animals treated with mesoporous PDA NPs modified with iron (MPDAFe NPs), coated with the cancer cell membrane and loaded with doxorubicin (DOX), and subsequently subjected to PTT. Methods: Liver and kidney homogenates were obtained from BALB/c nude mice with xenograft HepG2 human hepatoma cells, treated with iron modified mesoporous PDA nanoparticles, coated with the cancer cell membrane and loaded with doxorubicin (MPDAFe@DOX@Mem NPs), and subjected to PTT. These samples were used for histological evaluation and measurement of oxidative stress biomarkers, including total protein (TP), reduced glutathione (GSH), nitric oxide (NO), S-nitrosothiols (RSNO), thiobarbituric acid reactive substances (TBARS), trolox equivalent antioxidant capacity (TEAC), catalase (CAT), glutathione S-transferase (GST), and superoxide dismutase (SOD). Results: In the kidney, MPDAFe@DOX@Mem NPs in combination with PTT increased GSH (43%), TBARS (32%), and CAT (27%), while SOD decreased by 20% compared to the control group. Additionally, CAT activity in the liver increased by 79%. Conclusion: Significant differences in oxidative stress parameters and histological changes after administration with MPDAFe@DOX@Mem NPs and PTT were observed in the kidneys, showing more pronounced changes than the liver, indicating potential kidney toxicity. Our research provides insights into oxidative stress and possible toxic effects after in vivo administration of mesoporous PDA NPs combined with chemotherapy-photothermal therapy (CT-PTT), which is extremely important for their future applications in anticancer therapies. Keywords: polydopamine nanoparticles, oxidative stress, liver cancer model, in vivo toxicity, chemo- and photothermal therapy Graphical Polydopamine is a biopolymer obtained by polymerization of dopamine monomers, inspired by compounds used by mussels to stick to various surfaces. 1,2 Polydopamine nanoparticles have been of great interest to researchers for over fifteen years and have found a wide application in many areas of material chemistry, tissue engineering, implants, and nanomedicine. 3–7 The successful use of this biomimetic polymer to create various materials applied in medicine can be attributed to a set of unique physicochemical properties. The good adhesive properties of PDA allow it to cover virtually any type of material, including hydrophobic surfaces and various groups of nanoparticles and scaffolds. It is worth emphasizing that PDA is known to chelate almost all kinds of metals. This enables the attachment of paramagnetic metal ions to nanomaterials, providing them with contrast properties for MRI, which is particularly valuable for diagnostic approach. 6,8 Additionally, a wide range of PDA functionalization methods have been described for biomolecules and polymers for various applications. 6,7,9–11 The first major turning point for the role of polydopamine in nanomedicine was its use as a nanocarrier for drug delivery. 12 Thanks to its catechol, amine, and quinone groups, PDA can react with drugs b -Abstract Truncated-

Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage

The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage

Mineral and Bone Disorder in Chinese Dialysis Patients: a Multicenter Study

Combined Placental Mesenchymal Stem Cells with Guided Nanoparticles Effective Against Diabetic Nephropathy in Mouse Model

A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial

Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo.

Polyethylene Glycol Modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles for Enhanced Magnetic Tumor Targeting

Toxicity and Oxidative Stress Biomarkers in the Organs of Mice Treated with Mesoporous Polydopamine Nanoparticles Modified with Iron and Coated with Cancer Cell Membrane

Insulin-like 3 expression and fibrosis induction after intra-testicular injection of magnetic nanoparticles in rat testis and the ameliorative role of Echinacea purpurea extract

The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-Related Peritonitis: Study Protocol for a Randomized Controlled Clinical Trial.

Characterization and Hemocompatibility of α, β, and γ Cyclodextrin-Modified Magnetic Nano-Adsorbents

1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice

In Vivo Assessment of Hepatotoxicity, Nephrotoxicity and Biodistribution Using 3-Aminopropyltriethoxysilane-coated Magnetic Nanoparticles (Apts-Mnps) in ICR Mice

Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor

The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation

Dual-responsive renal injury cells targeting nanoparticles for vitamin E delivery to treat ischemia reperfusion-induced acute kidney injury

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.

Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies

Vitamin D Toxicity Managed with Peritoneal Dialysis

Effect of multidisciplinary medical nutrition therapy on the nutrition status of patients receiving peritoneal dialysis: A randomized controlled trial

Daunorubicin-loaded Magnetic Nanoparticles of Fe(3)O(4) Greatly Enhance the Responses of Multidrug-Resistant K562 Leukemic Cells in a Nude Mouse Xenograft Model to Chemotherapy.